China Resources Pharmaceutical (03320): KPC's net loss for the first nine months was about 363 million yuan, a year-on-year profit to loss

According to the Zhitong Finance App, China Resources Pharmaceutical (03320) announced the results of Kunming Pharmaceutical Group for the first nine months of 2026. Total operating revenue was about 2,722 billion yuan, a year-on-year decrease of 42.7%; net loss was about 363 million yuan, a year-on-year profit and loss.